Scripps Laboratories has high-quality recombinant cardiac markers for use in research or diagnostic assay development. Starting material shortages have impacted the supply of native cardiac markers to diagnostic assay manufacturers. Recombinant cardiac markers are a reliable and economical solution for assay development now and into the future. Learn more about them now.

 Recombinant Cardiac Markers for Sustainable Growth 

Creatine Kinase MB - ≥95% | Creatine Kinase MB - partially pure | Human Troponin T - Lyophilized | Human Troponin T - Liquid

View Recombinant CK-MB Data • View Recombinant TnT Data

Scripps Laboratories is proud to share with you our unwavering and dedicated efforts to develop a comprehensive portfolio of recombinant cardiac markers. Our native markers have powered your clinical diagnostic assays for more than 35 years. We have earned your trust during this period, as we are among the largest worldwide producers of native Creatine Kinase MB (CK-MB), Myoglobin, C-Reactive Protein (CRP) and more. Now, we are focusing our decades of expertise on the production of an elite line of recombinant cardiac markers.

 If your research or assay development interest is monitoring cardiac marker release profiles for the diagnosis of myocardial infarction (MI), Scripps Laboratories is developing sustainable recombinant products to assist your work: Recombinant CK-MB and Troponin T are available now and Myoglobin, Troponin I, Troponin IC Complex, and Troponin ITC Complex will be available soon. Or, if your interest is myocardial stress and assessing individuals at risk for MI, recombinant forms of CRP, Galectin-3, and NT-proBNP are in development as well.

Recombinant CK-MB and Troponin T are Available Now: